William Grossman's most recent trade in enGene Holdings Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| enGene Holdings Inc | William Grossman | Director, Interim Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| enGene Holdings Inc | William Grossman | Director, Interim Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 66,660 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 32,335 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 22,500 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 15,000 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| enGene Holdings Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Grossman William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) |